Next-Generation Hypertension Management: Therapies, Devices, and Decision-Making-Managing the Patient with Resistant Hypertension

Video Transcription

Video Summary

Eileen Hanberg discusses managing resistant hypertension through ongoing assessment, patient partnership, and individualized treatment. Before labeling hypertension as truly resistant, clinicians should confirm medication adherence, assess access and affordability, review lifestyle factors and interfering drugs, and investigate secondary causes—especially primary aldosteronism, which is common in this population.<br /><br />Team-based care, home or remote blood-pressure monitoring, family involvement, affordable prescriptions, combination pills, and achievable lifestyle goals can improve adherence. Regularly assess side effects and adjust treatment gradually, generally every six to eight weeks, until blood-pressure targets are reached.<br /><br />Three cases illustrate pseudo-resistance from skipped diuretics and medications, NSAID use, medication intolerance, and persistent hypertension despite adherence. For complex patients, consider specialist referral to a hypertension center, newer therapies, or renal denervation when appropriate. Lifestyle changes remain fundamental, and selecting medications that address multiple conditions can reduce pill burden.

Meta Tag

Concept Refractory Hypertension

Concept Pseudoresistance

Concept Secondary Hypertension

Concept Medication Adherence

Concept Hyperaldosteronism

Keywords

resistant hypertension

patient adherence

primary aldosteronism

blood pressure monitoring

renal denervation

Refractory Hypertension

Pseudoresistance

Secondary Hypertension

Medication Adherence

Hyperaldosteronism